Could your own belly fat help fight MS?

NCT ID NCT03461419

Terminated Disease control Sponsor: Healeon Medical Inc Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests whether a patient's own fat cells, processed into a special mixture called stromal vascular fraction, can safely improve quality of life and slow nerve damage in multiple sclerosis. About 100 adults with stable MS who have lasting nerve problems will receive an IV infusion of their own cells. The trial is currently suspended, and it is too early to know if this approach works.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: autologous adipose-derived cellular stromal vascular fraction (AD-cSVF)
What this could lead to: If it works, this could point toward a new way to manage multiple sclerosis by using the body's own cells to calm the immune system.
What could go wrong: The trial is suspended and early-stage, with no phase assigned. It is small (100 people) and uses a complex procedure that may not show clear benefit or could cause side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AUTOIMMUNE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

autoimmune disease demyelinating disease multiple sclerosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AUTOIMMUNE MULTIPLE SCLEROSIS

Contacts and locations

Locations

Global Alliance of Regenerative Medicine (GARM) International

Roatán, Hn, Honduras, Honduras
Robert W. Alexander, MD, FICS, LLC

Stevensville, Montana, 59870, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.